Patents by Inventor Duk Bae

Duk Bae has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11785948
    Abstract: The present disclosure relates to bacteriophage ?CJ28 (KCCM11466P) and a composition containing the same as an active ingredient. Further, the present disclosure relates to a method for preventing and/or treating infective diseases caused by enterotoxic Escherichia coli (ETEC) of animals excluding humans by using the composition. A bacteriophage ?CJ28 (KCCM11466P) has a specific ability to kill enterotoxigenic Escherichia coli.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: October 17, 2023
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi Shin, Gi Duk Bae, Jae Won Kim
  • Patent number: 11491195
    Abstract: The present disclosure relates to a composition comprising a Lactobacillus plantarum CJLP475 strain deposited under Accession No. KCCM12287P; and a Lactobacillus plantarum CJLPl7 strain deposited under Accession No. KCCM12249P, and use thereof.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: November 8, 2022
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Yoon Tack Jang, Hee-Yeon Kim, Ho Jin Moon, Seo Hyung Woo, Kyung Min Lee, Sung Hun Kim, Gi Duk Bae
  • Patent number: 11458175
    Abstract: The present disclosure relates to a composition comprising a Lactobacillus plantarum CJLP475 strain deposited under Accession No. KCCM12287P; and a Lactobacillus plantarum CJLP243 strain deposited under Accession No. KCCM11045P, and use thereof.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: October 4, 2022
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Hee-Yeon Kim, Ho Jin Moon, Kyu Yeol Son, Kyung Min Lee, Yoon Tack Jang, Sung Hun Kim, Gi Duk Bae, Bong Joon Kim
  • Publication number: 20210401903
    Abstract: The present disclosure relates to a composition comprising a Lactobacillus plantarum CJLP475 strain deposited under Accession No. KCCM12287P; and a Lactobacillus plantarum CJLPl7 strain deposited under Accession No. KCCM12249P, and use thereof.
    Type: Application
    Filed: July 12, 2019
    Publication date: December 30, 2021
    Inventors: Yoon Tack JANG, Hee-Yeon KIM, Ho Jin MOON, Seo Hyung WOO, Kyung Min LEE, Sung Hun KIM, Gi Duk BAE
  • Publication number: 20210361724
    Abstract: The present disclosure relates to a composition comprising a Lactobacillus plantarum CJLP475 strain deposited under Accession No. KCCM12287P; and a Lactobacillus plantarum CJLP243 strain deposited under Accession No. KCCM11045P, and use thereof.
    Type: Application
    Filed: July 12, 2019
    Publication date: November 25, 2021
    Inventors: Hee-Yeon KIM, Ho Jin MOON, Kyu Yeol SON, Kyung Min LEE, Yoon Tack JANG, Sung Hun KIM, Gi Duk BAE, Bong Joon KIM
  • Patent number: 10925909
    Abstract: The present invention relates to a novel bacteriophage ?CJ24 (KCCM11462P) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic E. coli of birds by using the bacteriophage ?CJ24 (KCCM11462P) or the composition.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: February 23, 2021
    Assignee: CJ Cheiljedang Corporation
    Inventors: Eun Mi Shin, Gi Duk Bae, Jae Won Kim
  • Patent number: 10918727
    Abstract: Disclosed are a translationally controlled tumor protein derived-protein transduction domain (TCTP-PTD) having the ability to penetrate the cell membrane, and to the use thereof. The TCTP-PTD peptide is capable of improving the ability of a target substance to penetrate the cell membrane to thereby effectively deliver the target substance into a living body, including cells, tissue and blood. Thus, the TCTP-PTD peptide may be used for research purposes in vitro, and may be used for clinical purposes, including treatment of various diseases, delivery of contrast agents, etc., and may also be used for diagnostic purposes and in cosmetic applications.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: February 16, 2021
    Assignee: ICURE BNP CO., LTD.
    Inventors: Kyung Lim Lee, Hea Duk Bae, Jee Hye Maeng
  • Patent number: 10822590
    Abstract: The present invention relates to a novel bacteriophage ?CJ25 (KCCM11463P) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic Escherichia coli (APEC) of birds by using the bacteriophage ?CJ25 (KCCM11463P) or the composition.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: November 3, 2020
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi Shin, Gi Duk Bae, Jae Won Kim
  • Patent number: 10704027
    Abstract: Provided is a novel bacteriophage ?CJ23 (KCCM11365P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ?CJ23 (KCCM11365P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases by avian pathogenic Escherichia coli(APEC) in birds using the bacteriophage ?CJ23(KCCM11365P) or the antibacterial composition containing the bacteriophage ?CJ23(KCCM11365P) as an active ingredient.
    Type: Grant
    Filed: March 19, 2018
    Date of Patent: July 7, 2020
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Hyo Seel Seo, Eun Mi Shin, Gi Duk Bae, Jae Won Kim
  • Publication number: 20200190483
    Abstract: The present invention relates to a novel bacteriophage ?CJ28 (KCCM11466P) and a composition containing the same as an active ingredient. Further, the present invention relates to a method for preventing and/or treating infective diseases caused by enterotoxic Escherichia coli (ETEC) of animals excluding humans by using the composition. A bacteriophage ?CJ28 (KCCM11466P) has a specific ability to kill enterotoxigenic Escherichia coli.
    Type: Application
    Filed: February 27, 2020
    Publication date: June 18, 2020
    Inventors: Eun Mi SHIN, Gi Duk BAE, Jae Won KIM
  • Patent number: 10577590
    Abstract: The present invention relates to a novel bacteriophage ?CJ28 (KCCM11466P) and a composition containing the same as an active ingredient. Further, the present invention relates to a method for preventing and/or treating infective diseases caused by enterotoxic Escherichia coli (ETEC) of animals excluding humans by using the composition.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: March 3, 2020
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi Shin, Gi Duk Bae, Jae Won Kim
  • Publication number: 20190262409
    Abstract: The present disclosure relates to a novel Lactobacillus sakei strain and a composition comprising the same.
    Type: Application
    Filed: April 1, 2019
    Publication date: August 29, 2019
    Applicant: CJ Cheiljedang Corporation
    Inventors: Da Hye JEONG, Young Mee CHUNG, Bong Joon KIM, So Young KIM, Hyun Sun YUN, Byoung Seok MOON, Jie Eun PARK, Gi Duk BAE, Hee Yoon AHN, Jae Ho JANG
  • Publication number: 20190224258
    Abstract: The present invention relates to a novel bacteriophage ?CJ24 (KCCM11462P) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic E. coli of birds by using the bacteriophage ?CJ24 (KCCM11462P) or the composition.
    Type: Application
    Filed: April 9, 2019
    Publication date: July 25, 2019
    Inventors: Eun Mi SHIN, Gi Duk BAE, Jae Won KIM
  • Publication number: 20190153399
    Abstract: The present invention relates to a novel bacteriophage ?CJ25 (KCCM11463P) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic Escherichia coli (APEC) of birds by using the bacteriophage ?CJ25 (KCCM11463P) or the composition.
    Type: Application
    Filed: January 17, 2019
    Publication date: May 23, 2019
    Inventors: Eun Mi Shin, Gi Duk Bae, Jae Won Kim
  • Patent number: 10286020
    Abstract: The present invention relates to a novel bacteriophage ?CJ24 (KCCM11462P) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic E. coli of birds by using the bacteriophage ?CJ24 (KCCM11462P) or the composition.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: May 14, 2019
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi Shin, Gi Duk Bae, Jae Won Kim
  • Publication number: 20190111141
    Abstract: Disclosed are a translationally controlled tumor protein derived-protein transduction domain (TCTP-PTD) having the ability to penetrate the cell membrane, and to the use thereof. The TCTP-PTD peptide is capable of improving the ability of a target substance to penetrate the cell membrane to thereby effectively deliver the target substance into a living body, including cells, tissue and blood. Thus, the TCTP-PTD peptide may be used for research purposes in vitro, and may be used for clinical purposes, including treatment of various diseases, delivery of contrast agents, etc., and may also be used for diagnostic purposes and in cosmetic applications.
    Type: Application
    Filed: April 6, 2017
    Publication date: April 18, 2019
    Applicant: Ewha University - Industry Collaboration Foundation
    Inventors: Kyung Lim Lee, Hea Duk Bae, Jee Hye Maeng
  • Patent number: 10240129
    Abstract: The present invention relates to a novel bacteriophage ?CJ25 (KCCM11463P) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic Escherichia coli (APEC) of birds by using the bacteriophage ?CJ25 (KCCM11463P) or the composition.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: March 26, 2019
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi Shin, Gi Duk Bae, Jae Won Kim
  • Publication number: 20180282703
    Abstract: Provided is a novel bacteriophage ?CJ23 (KCCM11365P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ?CJ23 (KCCM11365P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases by avian pathogenic Escherichia coli(APEC) in birds using the bacteriophage ?CJ23(KCCM11365P) or the antibacterial composition containing the bacteriophage ?CJ23(KCCM11365P) as an active ingredient.
    Type: Application
    Filed: March 19, 2018
    Publication date: October 4, 2018
    Inventors: Hyo Seel SEO, Eun Mi SHIN, Gi Duk BAE, Jae Won KIM
  • Patent number: 9956256
    Abstract: The present invention relates to a novel bacteriophage ?CJ26 (KCCM11464P) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by Salmonella by using the bacteriophage ?CJ26 (KCCM11464P) or the composition.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: May 1, 2018
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi Shin, Bo Kyung Son, Gi Duk Bae, Jae Won Kim
  • Patent number: 9950018
    Abstract: The present invention relates to a novel bacteriophage ?CJ27 (KCCM11465P) and a composition containing the same as an active ingredient. Further, the present invention relates to a method for preventing and/or treating infective diseases caused by enterotoxic Escherichia coli (ETEC) of non-human animals using the ?CJ27 (KCCM11465P) and the composition.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: April 24, 2018
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi Shin, Gi Duk Bae, Jae Won Kim